The newsetters are in PDF format and require Adobe Acrobat Reader to view. If you do not already have Acrobat Reader, you can download it here for free.
Need these files as accessible for the disabled? Visit http://access.adobe.com
Resident Research
Resident Research is a booklet of the research conducted by our residents each year.
Residents' Roar
Residents' Roar is a newsletter about our residents and the residency program.
Scientific Research: Publications by Current and Former Residents
This list represents self-reports and a search of the literature. We apologize for any inadvertent ommissions or oversights.
Abel EE, Kane-Gill SL, Seybert AL, Kellum JA. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: Comparison of clinical outcomes. Am J Health Syst Pharm. 2012;69(18):1559-67.
Alaniz C, Pogue JM. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial. Ann Pharmacother. 2012;46(10):1432-5.
American College of Clinical Pharmacy, Rathbun RC, Hester EK, Arnold LM, Chung AM, Dunn SP, Harinstein LM, Leber M, Murphy JA, Schonder KS, et al. Importance of direct patient care in advanced pharmacy practice experiences. Pharmacotherapy. 2012;32(4):e88-97.
Arif SA, Gim S, Nogid A, Shah B. Journal clubs during advanced pharmacy practice experiences to teach literature-evaluation skills. Am J Pharm Ed. 2012;76(5):2012:Article 88.
Armahizer MJ, Johnson D, Deusenberry CM, Foley JJ, Krenzelok EP, Pummer TL. Evaluation of pharmacist utilization of a poison center as a resource for patient care. J Pharm Pract. 2012 Jul 25. [Epub ahead of print]
Aspinall SL, Cunningham FE, Zhao X, et al; ESA Clinic Study Group. Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD. Am J Kidney Dis. 2012;60(3):371-9.
Berdine H, Dougherty T, Ference J, Karpa K, Klootwyk J, Kozminski M, et al. The pharmacists' role in the Patient-Centered Medical Home (PCMH): a white paper created by the Health Policy Committee of the Pennsylvania Pharmacists Association (PPA). Ann Pharmacother. 2012;46(5):723-50.
Blume OR, Yost SE, Kaplan B. Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes. J Transplant. 2012;2012:201754.
Casapao AM, Steed ME, Levine DP, Rybak MJ. Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection. Expert Opin Pharmacother. 2012;13(8):1177-86.
Cesarz JL, Steffenhagen AL, Svenson J, Hamedani AG. Emergency department discharge prescription interventions by emergency medicine pharmacists. Ann Emerg Med. 2012 May 24. [Epub ahead of print]
Chopra T, Marchaim D, Veltman J, Johnson P, Zhao JJ, Tansek R, Hatahet D, Chaudhry K, Pogue JM, et al. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother. 2012;56(7):3936-42.
Collins VL, Marchaim D, Pogue JM, et al. Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2012;56(4):2173-7.
Cribb J. O'Brien K. DeRemer CE. Rifaximin in combination with metronidazole and oral vancomycin for the treatment of an initial episode of Clostridium difficile associated diarrhea: case report and literature review. Hosp Pharm 2012;47(3):1-8.
Curtin LB, Cawley MJ. Immunoassay cross-reactivity of phenylephrine and methamphetamine. Pharmacotherapy. 2012;32(5):e98-102.
DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP; GS-236-0103 Study Team. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet. 2012;379(9835):2429-38.
Desimone ME, Blank GE, Virji M, Donihi A, et al. Effect of an educational Inpatient Diabetes Management Program on medical resident knowledge and measures of glycemic control: a randomized controlled trial. Endocr Pract. 2012;18(2):238-49.
Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy. 2012 Jul;32(7):613-7.
Devabhakthuni S, Armahizer MJ, Dasta JF, Kane-Gill SL. Analgosedation: A paradigm shift in intensive care unit sedation practice. Ann Pharmacother. 2012;46:530-540.
Devabhakthuni S, Gonzales JP, Tata AL et al. Evaluation of vancomycin dosing and monitoring in adult medicine patients. Hosp Pharm. 2012;47(6):451-459.
Eisenhower C, Farrington EA. Advancements in the treatment of head lice in pediatrics. J Pediatr Health Care. 2012;26(6):451-61.
Elliott JP, Koerner PH, Heasley J, Kamal KM. The impact of elective active-learning courses in pregnancy/lactation and pediatric pharmacotherapy. Am J Pharm Educ. 2012;76(2):26.
Elliott RA, Tran T, Taylor SE, et al. Impact of a pharmacist-prepared interim residential care medication administration chart on gaps in continuity of medication management after discharge from hospital to residential care: a prospective pre- and post-intervention study (MedGap Study). BMJ Open. 2012;25;2(3).
Fink JC, Joy MS, St Peter WL, Wahba IM; ASN Chronic Kidney Disease Advisory Group. Finding a common language for patient safety in CKD. Clin J Am Soc Nephrol. 2012;7(4):689-95.
Firstenberg MS, Abel EE, Papadimos TJ, Tripathi RS. Nonconvective forces: a critical and often ignored component in the echocardiographic assessment of transvalvular pressure gradients. Cardiol Res Pract. 2012;2012:383217.
Firstenberg MS, Nelson K, Abel E, McGregor J, Eiferman D. Extracorporeal membrane oxygenation for complex multiorgan system trauma. Case Rep Surg. 2012;2012:897184.
Firstenberg MS, Tripathi RS, Grose NA, Abel E, Peters SB, Papadimos TJ. Calciphylaxis following coronary artery bypass surgery: an underappreciated cause of wound complications? Heart Surg Forum. 2012;15(4):E218-20.
Fukuta Y, Clarke LG, Shields RK, et al. Lack of seasonality in the occurrence of multidrug-resistant Acinectobacter baumannii complex. Infect Control Hosp Epidemiol. 2012;33(10):1051-2.
German P, Liu HC, Szwarcberg J, Hepner M, Andrews J, Kearney BP, Mathias A. Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function. J Acquir Immune Defic Syndr. 2012;61(1):32-40.
Gokhman R, Seybert AL, Phrampus P, Darby J, Kane-Gill SL. Medication errors during medical emergencies in a large, tertiary care, academic medical center. Resuscitation. 2012;83(4):482-7.
Griffiths RI, Barron RL, Gleeson ML, et al. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer. Pharmacoeconomics. 2012;30(2):103-18.
Guetschow T, Steffenhagen A. Justification of a pharmacy technician position: An evaluation of the benefits of a pharmacy technician completing pre-surgical patient medication histories pre-operatively by telephone. JPSW. 2012 May/June;15(3):52-53.
Harinstein LM, Kane-Gill SL, Smithburger PL, et al. Use of an abnormal laboratory value-drug combination alert to detect drug-induced thrombocytopenia in critically Ill patients. J Crit Care. 2012;27(3):242-9.
Hawkins K, Donihi AC, Korytkowski MT. Glycemic management in medical and surgical patients in the non-ICU setting. Curr Diab Rep. 2012 Oct 26. [Epub ahead of print]
Hayakawa K, Marchaim D, Divine GW, Pogue JM, et al. Growing prevalence of Providencia stuartii associated with the increased usage of colistin at a tertiary health care center. Int J Infect Dis. 2012;16(9):e646-8.
Hayakawa K, Marchaim D, Martin ET, Tiwari N, Yousuf A, Sunkara B, Pulluru H, Kotra H, Hasan A, Bheemreddy S, Sheth P, Lee DW, Kamatam S, Bathina P, Nanjireddy P, Chalana IK, Patel S, Kumar S, Vahia A, Ku K, Yee V, Swan J, Pogue JM, Lephart PR, Rybak MJ, Kaye KS. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia. Antimicrob Agents Chemother. 2012;56(5):2452-8.
Hayakawa K, Marchaim D, Palla M, Mahesh Gudur U, Pulluru H, Bathina P, Alshabani K, Govindavarjhulla A, Mallad A, Reddy Abbadi D, Chowdary D, Kakarlapudi H, Guddati H, Das M, Kannekanti N, Vemuri P, Doddamani R, Ram Rakesh Mundra V, Reddy Guddeti R, Policherla R, Bai S, Lohithaswa S, Prasad Shashidharan S, Chidurala S, Diviti S, Sukayogula K, Joseph M, Pogue JM, et al. Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study. Antimicrob Agents Chemother. 2012 Oct 15. [Epub ahead of print]
Hegde SS, Okusanya OO, Skinner R, et al. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model. Antimicrob Agents Chemother. 2012;56(3):1578-83.
Innis CJ, Ceresia ML, Merigo C, Scott Weber E 3rd, Papich MG. Single-dose pharmacokinetics of ceftazidime and fluconazole during concurrent clinical use in cold-stunned Kemp's ridley turtles (Lepidochelys kempii). J Vet Pharmacol Ther. 2012;35(1):82-9.
Jernigan MG, Press EG, Nguyen MH, Clancy CJ, Shields RK. The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2012;56(6):3395-8.
Joy MS, La M, Wang J, et al. Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Br J Clin Pharmacol. 2012;74(3):445-55.
Joy MS. Clinical Pharmacokinetics, 5th Edition. Ann Pharmacother. 2012 Mar 6. [Epub ahead of print]
Joy MS. Impact of glomerular kidney diseases on the clearance of drugs. J Clin Pharmacol. 2012;52(1 Suppl):23S-34S.
Kane-Gill SL, Forsberg EA, Verrico MM, Handler SM. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs. Drug Saf. 2012 Aug 1;35(8):645-53.
Kane-Gill SL, Post JP, Smithburger PL, Seybert AL. "Bump": using a mobile app to enhance learning in simulation scenarios. Simul Healthc. 2012;7(5):326-7.
Khandhar SJ, Shah HV, Shullo MA, et al. Long-term effects on renal function of dose-reduced calcineurin inhibitor and sirolimus in cardiac transplant patients. Clin Transplant. 2012;26(1):42-9.
Kim JJ, Culley CM, Mohammad RA. Telaprevir: An oral protease inhibitor for hepatitis C virus infection. Am J Health Syst Pharm. 2012;69(1):19-33.
Ku K, Pogue JM, Moshos J, et al. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections. Am J Infect Control. 2012 Mar 21. [Epub ahead of print]
Labelle A, Juang P, Reichley R, et al. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment. Crit Care Med. 2012;40(7):2016-21.
Lombardi LR, Miano TA, Davis JL, Morgan SC, Goldstein SC, Vardhanabhuti S, Mitra N, Vozniak JM. A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients. J Oncol Pharm Pract. 2012;18(1):3-9.
Lowery JB, Donihi AC, Korytkowski MT. U-500 insulin as a component of basal bolus insulin therapy in type 2 diabetes. Diabetes Technol Ther. 2012;14(6):505-7.
Lupu AM, Stewart AL, O’Neil C. Comparison of active-learning strategies for motivational interviewing skills, knowledge, and confidence in first-year pharmacy students. Am J Pharm Educ. 2012;76(2):28.
Lyman GH, Barron RL, Natoli JL, Miller RM. Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer. Crit Rev Oncol Hematol. 2012;81(3):296-308.
Mack DM, Kim JJ. Pharmacokinetic and Clinical Implications of Dabigatran Use in Severe Renal Impairment for Stroke Prevention in Non-Valvular Atrial Fibrillation. The Annals of Pharmacotherapy. 2012;46:1105-10.
Magaji V, Nayak S, Donihi AC, et al. Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery. Diabetes Technol Ther. 2012;14(11):1013-7.
Marchaim D, Chopra T, Bhargava A, Bogan C, Dhar S, Hayakawa K, Pogue JM, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33(8):817-30.
Marchaim D, Chopra T, Bogan C, Bheemreddy S, Sengstock D, Jagarlamudi R, Malani A, Lemanek L, Moshos J, Lephart PR, Ku K, Hasan A, Lee J, Khandker N, Blunden C, Geffert SF, Moody M, Hiro R, Wang Y, Ahmad F, Mohammadi T, Faruque O, Patel D, Pogue JM, et al. The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control. 2012;40(8):760-5.
Marchaim D, Perez F, Lee J, Bheemreddy S, Hujer AM, Rudin S, Hayakawa K, Lephart PR, Blunden C, Shango M, Campbell ML, Varkey J, Manickam P, Patel D, Pogue JM, et al. "Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control. 2012;40(9):830-5.
Marchaim D, Taylor AR, Hayakawa K, Bheemreddy S, Sunkara B, Moshos J, Chopra T, Abreu-Lanfranco O, Martin ET, Pogue JM, et al. Hospital bath basins are frequently contaminated with multidrug-resistant human pathogens. Am J Infect Control. 2012;40(6):562-4.
Mark SM, McMillen K, Davis SJ. Hidden costs of pharmacy technology. Hosp Pharm. 2012;47(8):653-660.
Martello JL, Woytowish MR, Chambers H. Ecallantide for treatment of acute attacks of hereditary angioedema. Am J Health Syst Pharm. 2012 Apr 15;69(8):651-7.
Martin ET, Tansek R, Collins V, Hayakawa K, Abreu-Lanfranco O, Chopra T, Lephart PR, Pogue JM, et al. The carbapenem-resistant Enterobacteriaceae score: A bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients. Am J Infect Control. 2012 Aug 30. [Epub ahead of print]
McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Sax PE. Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS. 2012;26(11):1371-85.
Mebel E, Davlin M. Managing the logistics of transitioning between PGY1 and PGY2 pharmacy residencies. Am J Health Syst Pharm. 2012;69(5):374-5.
Mehta U, Clerk C, Allen E, et al. Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings. BMC Pregnancy Childbirth. 2012;12(1):89.
Michels SL, Barron RL, Reynolds MW, et al. Costs associated with febrile neutropenia in the US. Pharmacoeconomics. 2012;30(9):809-23
Mitsani D, Nguyen MH, Shields RK, et al. Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity. Antimicrob Agents Chemother. 2012;56(5):2371-7.
Momper JD, Zhao Y, Shapiro R, Schonder KS, et al. Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. Transpl Infect Dis. 2012 Oct 2. [Epub ahead of print]
Neofytos D, Lombardi LR, Shields RK, et al. Administration of voriconazole in patients with renal dysfunction. Clin Infect Dis. 2012;54(7):913-21.
Newton M, Martello JL. Surviving in a cofunded faculty appointment. Am J Health Syst Pharm. 2012;69: 102-104.
O'Connor SK, Ferreri SP, Michaels NM, Greco AJ, et al. Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. Pharmacogenomics. 2012;13(8):955-62.
Osborne M, Snyder M, Hall D, et al. Evaluating Pennsylvania Pharmacists’ Provision of Community-based Patient Care Services to Develop a Statewide Practice Network. INNOVATIONS in Pharmacy. 2011; 2(4): Article 61.
Pikoulas TE, Fuller MA. Dalfampridine: a medication to improve walking in patients with multiple sclerosis. Ann Pharmacother. 2012;46(7-8):1010-5.
Pincus KJ, Tata AL, Watson K. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis. Ann Pharmacother. 2012;46(6):873-8.
Polischuk E, Vetterly CG, Crowley KL, et al. Implementation of a standardized process for ordering and dispensing of high-alert emergency medication infusions. J Pediatr Pharmacol Ther. 2012;17(2):166-72.
Raina A, Horn ET, Benza RL. The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists. Transplantation. 2012 Oct 3. [Epub ahead of print]
Sax PE, DeJesus E, Mills A, Zolopa A, Cohen C, Wohl D, Gallant JE, Liu HC, Zhong L, Yale K, White K, Kearney BP, Szwarcberg J, Quirk E, Cheng AK; GS-US-236-0102 study team. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks. Lancet. 2012;379(9835):2439-48. Erratum in: Lancet. 2012 Aug 25;380(9843):730.
Seybert AL, Smithburger PL, Kobulinsky LR, Kane-Gill SL. Simulation-based learning versus problem-based learning in an acute care pharmacotherapy course. Simul Healthc. 2012;7(3):162-5.
Shah S, Sarwar U, King EA, Lat A. Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient. Transpl Infect Dis. 2012;14(4):398-402.
Shields RK, Clancy CJ, Minces LR, et al. Staphylococcus aureus infections in the early period after lung transplantation: Epidemiology, risk factors, and outcomes. J Heart Lung Transplant. 2012;31(11):1199-206.
Shields RK, Nguyen MH, Press EG, et al. The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother. 2012;56(9):4862-9.
Shields RK, Nguyen MH, Shullo MA, et al. Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome. Scand J Infect Dis. 2012 Jul 25. [Epub ahead of print]
Shill J, Taylor DM, Ngui B, Taylor SE, et al. Factors associated with high levels of patient satisfaction with pain management. Acad Emerg Med. 2012;19(10):1212-1215.
Singh-Franco D, Elrod S, Harrington C, McLaughlin-Middlekauff J. Response letter. Diabetes Obes Metab. 2012;14(11):1056-7.
Singh-Franco D, McLaughlin-Middlekauff J, Elrod S, Harrington C. The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Obes Metab. 2012;14(8):694-708.
Smithburger PL, Kane-Gill SL, Ruby CM, Seybert AL. Comparing effectiveness of 3 learning strategies: simulation-based learning, problem-based learning, and standardized patients. Simul Healthc. 2012;7(3):141-6.
Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. Int J Pharm Pract. 2012;20(6):402-8.
Starner CI, Fenrick B, Coleman J, Wickersham P, Gleason PP. Rosiglitazone prior authorization safety policy: a cohort study. J Manag Care Pharm. 2012;18(3):225-33.
Tulman DB, Tripathi RS, Abel EE, Papadimos TJ. Cardiac cachexia and the aged: death by water, wind, Earth, and fire. J Am Geriatr Soc. 2012;60(10):1999-2000.
Wanek MR, Horn ET, Elapavaluru S, et al. Safe use of hemodialysis for dabigatran removal before cardiac surgery. Ann Pharmacother. 2012;46(9):e21.
Wisniewski CS, Robert S. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia. Ann Pharmacother. 2012;46(7-8):1097-104.
Yost SE, Kaplan B. Comparing kidney transplant outcomes; caveats and lessons. Nephrol Dial Transplant. 2012 Sep 17. [Epub ahead of print]
Zillich AJ, Jaynes HA, Snyder ME, et al. Evaluation of specialized medication packaging combined with medication therapy management: adherence, outcomes, and costs among Medicaid patients. Med Care. 2012;50(6):485-93.
Abu-Ramaileh AM, Shane R, Churchill W, Steffenhagen A et al. Evaluating and classifying pharmacists' quality interventions in the emergency department. Am J Health Syst Pharm. 2011;68(23):2271-5.
Benedict N, Schonder K. Patient simulation software to augment an advanced pharmaceutics course. Am J Pharm Educ. 2011;75(2):21.
Bhama JK, Pilewski JM, Zaldonis D, Fontes PA, DeVera ME, Shullo MA et al. Does simultaneous lung-liver transplantation provide an immunologic advantage compared with isolated lung transplantation? J Thorac Cardiovasc Surg. 2011;141(5):e36-8.
Blommel ML, Blommel AL. Dabigatran etexilate: A novel oral direct thrombin inhibitor. Am J Health Syst Pharm. 2011;68(16):1506-19.
Bragg SW. Positive educational impact of mandatory student teaching sessions. Am J Pharm Educ.
Brown M, Polisetty R, Gracely EJ, Cuhaci B, Schlecht HP. Weight-based loading of vancomycin in patients on hemodialysis. Clin Infect Dis. 2011;53(2):164-6.
Byrne R, Yost SE, Kaplan B. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes? Clin Pharmacol Ther. 2011 Aug;90(2):204-6.
Cohen C, Elion R, Ruane P, Shamblaw D, DeJesus E, Rashbaum B, Chuck SL, Yale K, Liu HC, Warren DR, Ramanathan S, Kearney BP. Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection. AIDS. 2011;25(6):F7-12.
Coons JC, McGraw M, Murali S. Pharmacotherapy for acute heart failure syndromes. Am J Health Syst Pharm. 2011;68(1):21-35.
Crowther DM, Buck ML, McCarthy MW, Barton VW. Improving pediatric adverse drug event reporting through clinical pharmacy services. J Pediatr Pharmacol Ther. 2011;16(4):285-90.
Curtin LB, Finn LA, Czosnowski QA, et al. Computer-based simulation training to improve learning outcomes in mannequin-based simulation exercises. Am J Pharm Educ. 2011;75(6):113.
Davis SJ. Proposal for pharmacy residency leadership certificates. Am J Health Syst Pharm. 2011;68(18):1693-4.
DeRemer CE, Fleming VH, Brown S, May JR. Evaluation of pain management documentation. South Med J. 2011;104(9):629-33.
DeRemer CE, Gujral JS, Thornton JW, Sorrentino RA. Dabigatran falsely elevates point of care international normalized ratio results. Am J Med. 2011;124(9):e5-6.
Devabhakthuni S, Pajoumand M, Williams C, Kufera JA, Watson K, Stein DM. Evaluation of Dexmedetomidine: Safety and Clinical Outcomes in Critically Ill Trauma Patients. J Trauma. 2011;71(5):1164-1171.
Devabhakthuni S, Seybert AL. Oral antiplatelet therapy for the management of acute coronary syndromes: defining the role of prasugrel. Crit Care Nurse. 2011;31(1):51-63. Epub 2010 Jun 30.
DiNardo M, Donihi AC, Forte P, Gieraltowski L, Korytkowski M. Standardized glycemic management and perioperative glycemic outcomes in patients with diabetes mellitus who undergo same-day surgery. Endocr Pract. 2011;17(3):404-11.
Donihi AC, Gibson JM, Noschese ML et al. Effect of a targeted glycemic management program on provider response to inpatient hyperglycemia. Endocr Pract. 2011;17(4):552-7.
Elion R, Cohen C, Gathe J, Shalit P, Hawkins T, Liu HC, Mathias AA, Chuck SL, Kearney BP, Warren DR; GS-US-216-0105 Study Team. Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection. AIDS. 2011;25(15):1881-6.
Ensor CR, Trofe-Clark J, Gabardi S, McDevitt-Potter LM, Shullo MA. Generic maintenance immunosuppression in solid organ transplant recipients. Pharmacotherapy. 2011;31(11):1111-29.
Falcione BA, Joyner PU, Blouin RA et al. New directions in pharmacy education. J Am Pharm Assoc (2003). 2011;51(6):678-82.
Ference JD. STEPS approach allows patient to participate in decision making. Am Fam Physician. 2011;83(1):8.
Firstenberg MS, Abel E, Blais D et al. Temporary extracorporeal circulatory support and pulmonary embolectomy for catastrophic amniotic fluid embolism. Heart Surg Forum. 2011;14(3):E157-9.
Firstenberg MS, Abel EE, Papadimos TJ, Tripathi RS. Nonconvective forces: a critical and often ignored component in the echocardiographic assessment of transvalvular pressure gradients. Cardiol Res Pract. 2012;2012:383217.
Firstenberg MS, Blais D, Abel E, Go MR. Superior vena cava bypass with cryopreserved ascending aorta allograft. Ann Thorac Surg. 2011;91(3):905-7.
Garwood CL, Gortney JS, Corbett TL. Is there a role for fondaparinux in perioperative bridging? Am J Health Syst Pharm. 2011;68(1):36-42.
Gokhman R, Seybert AL, Phrampus P, Darby J, Kane-Gill SL. Medication errors during medical emergencies in a large, tertiary care, academic medical center. Resuscitation. 2011 Oct 14. [Epub ahead of print]
Griffiths RI, Barron RL, Gleeson ML et al. Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer. Pharmacoeconomics. 2011 Oct 3. [Epub ahead of print]
Guglielmo BJ, Edwards DJ, Franks AS, Naughton CA, Schonder KS, et al. A critical appraisal of and recommendations for faculty development. Am J Pharm Educ. 2011;75(6):122.
Hanigan MH, Dela Cruz BL, Shord SS et al. Optimizing chemotherapy: concomitant medication lists. Clin Pharmacol Ther. 2011;89(1):114-9. Epub 2010 Dec 1.
Hardesty JS, Juang P. Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection. Pharmacotherapy. 2011;31(9):877-86.
Hayakawa K, Marchaim D, Vidaillac C, Lephart P, Pogue JM et al. Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2011 Sep;32(9):922-4.
Innis CJ, Ceresia ML, Merigo C, Scott Weber E 3rd, Papich MG. Single-dose pharmacokinetics of ceftazidime and fluconazole during concurrent clinical use in cold-stunned Kemp's ridley turtles (Lepidochelys kempii). J Vet Pharmacol Ther. 2011. [Epub ahead of print]
Jao K, McD Taylor D, Taylor SE, Khan M, Chae J. Simple clinical targets associated with a high level of patient satisfaction with their pain management. Emerg Med Australas. 2011;23(2):195-201.
Kane-Gill SL, Smithburger PL. Transitioning knowledge gained from simulation to pharmacy practice. Am J Pharm Educ. 2011;75(10):210.
Khandhar SJ, Shah HV, Shullo MA et al. Long-term effects on renal function of dose-reduced calcineurin inhibitor and sirolimus in cardiac transplant patients. Clin Transplant. 2011. [Epub ahead of print]
Knapp E, Watson K. Medication management of atrial fibrillation: emerging therapies for rhythm control and stroke prevention. P T. 2011;36(8):518-28.
Kozminski M, Busby R, McGivney MS et al. Pharmacist integration into the medical home: qualitative analysis. J Am Pharm Assoc (2003). 2011;51(2):173-83.
Kullar R, Leonard SN, Davis SL, Delgado G Jr, Pogue JM, Wahby KA, Falcione B, Rybak MJ. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy. 2011;31(5):441-8.
Kullar R, Leonard SN, Davis SL, Delgado G Jr, Pogue JM, Wahby KA, Falcione B, Rybak MJ. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy. 2011;31(5):441-8.
Last AR, Ference JD, Falleroni J. Pharmacologic treatment of hyperlipidemia. Am Fam Physician. 2011;84(5):551-8.
Lat A, Clock SA, Wu F, Whittier S, Della-Latta P, Fauntleroy K, Jenkins SG, Saiman L, Kubin CJ. Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest. J Clin Microbiol. 2011;49(5):1795-8. Epub 2011 Mar 2.
Lat A, Thompson GR 3rd. Update on the optimal use of voriconazole for invasive fungal infections. Infect Drug Resist. 2011;4:43-53. Epub 2011 Feb 3.
Lauffenburger JC, Jonkman LJ, Lange CE, Connor SE, Sibale C. A public-health approach to site-specific formulary management: addressing deficient drug supplies in Malawi. Int J Pharm Pract. 2011 Jun;19(3):201-5. Epub 2011 Apr 11.
Lavsa SM, Corman SL, Culley CM, Pummer TL. Reliability of Wikipedia as a medication information source for pharmacy students. Currents in Pharmacy Teaching & Learning 2011;3:154-8.
Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011;51(1):90-4.
Little J, Davis S, Goff J, Mulvanity M, Mark SM. Director’s Forum-Developing Patient-Centered Services, Part 4: Considerations in implementing a pediatric pharmacy practice model. Hosp Pharm. 2011;46(4):291-296.
Luong ML, Clancy CJ, Vadnerkar A, Kwak EJ, Silveira FP, Wissel MC, Grantham KJ, Shields RK, et al. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin Infect Dis. 2011;52(10):1218-26.
Lyman GH, Barron RL, Natoli JL, Miller RM. Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer. Crit Rev Oncol Hematol. 2011 May 31. [Epub ahead of print]
Marchaim D, Chopra T, Perez F, Hayakawa K, Lephart PR, Bheemreddy S, Blunden C, Hujer AM, Rudin S, Shango M, Campbell M, Varkey J,
Slim J, Ahmad F, Patel D, Chen TY, Pogue JM, et al. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit Medical Center. Infect Control Hosp Epidemiol. 2011;32(9):861-71.
Marchaim D, Chopra T, Pogue JM et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother. 2011;55(2):593-9. Epub 2010 Nov 29.
McCarthy MW. Valuing your medical practice--Part 2: Understanding the components used to determine a fair and marketable price. Md Med. 2011;12(1):23-4, 33.
McComsey GA, Kitch D, Sax PE, Tebas P, Tierney C, Jahed NC, Myers L, Melbourne K, Ha B, and Daar ES. Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s. Clinical Infectious Diseases 2011;53(2):185–196.
McComsey GA, Kitch D, Daar ES , Tierney C , Jahed NC, Tebas P, Myers L, Melbourne K, Ha B, and Sax PE Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202. The Journal of Infectious Diseases 2011;203:1791–801.
McGivney MS, Hall DL, Stoehr GP, Donegan TE. An introductory pharmacy practice experience providing pharmaceutical care to elderly patients. Am J Pharm Educ. 2011;75(8):159.
Momper JD, Ridenour TA, Schonder KS, Shapiro R, Humar A, Venkataramanan R. The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant. 2011;11(9):1861-7. Epub 2011 Jun 30.
Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS, Nolin TD. Comparative Evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) Study Equation for Drug Dosing: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2011;31(11):1130-44.
Okusanya OO, Tsuji BT, Bülitta JB, Forrest A, Bulik CC, Bhavnani SM, Fernandes P, Ambrose PG. Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection. Diagn Microbiol Infect Dis. 2011 May;70(1):101-11.
Oyelami-Adeleye I, Abate MA, Blommel ML. Pharmacy patrons 'awareness of pharmacists' education and routine patient care responsibilities. J Pharm Pharm Sci. 2011;14(3):306-14.
Phan SV, Kreys TJ. Adjunct mirtazapine for negative symptoms of schizophrenia. Pharmacotherapy. 2011;31(10):1017-30.
Pogue JM, Alaniz C, Carver PL et al. Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia. Infect Control Hosp Epidemiol. 2011;32(3):289-92.
Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, Lephart P, Kaye KS. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011;53(9):879-84. Epub 2011 Sep 7.
Pogue JM, Marchaim D, Kaye D, Kaye KS. Revisiting "older" antimicrobials in the era of multidrug resistance. Pharmacotherapy. 2011;31(9):912-21.
Ramanathan S, Mathias AA, German P, Kearney BP. Clinical pharmacokinetic and pharmacodynamic profile of the HIV integrase inhibitor elvitegravir. Clin Pharmacokinet. 2011;50(4):229-44.
Rivkin A, Gim S. Rifaximin: new therapeutic indication and future directions. Clin Ther. 2011;33(7):812-27. Epub 2011 Jul 7.
Rodis JL, Schommer JC, Maguire MA. Building capacity for pharmacist-provided patient care services. J Am Pharm Assoc (2003). 2011;51(1):10-4.
Saely S, Kaye KS, Fairfax MR, Chopra T, Pogue JM. Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase-producing Klebsiella pneumoniae. Am J Infect Control. 2011;39(5):390-5. Epub 2011 Jan 21.
Schonder KS. Pharmacology of immunosuppressive medications in solid organ transplantation. Crit Care Nurs Clin North Am. 2011;23(3):405-23. Epub 2011 Aug 11.
Schwartz JL, Rountree W, Kashuba AD, Brache V, Creinin MD, Poindexter A, Kearney BP. A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel. PLoS One. 2011;6(10):e25974. Epub 2011 Oct 19.
Shields RK, Clancy CJ, Vadnerkar A et al. Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy. Antimicrob Agents Chemother. 2011;55(3):1308-11. Epub 2010 Dec 28.
Shields RK, Kwak EJ, Potoski BA et al. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis. 2011;70(2):246-52. Epub 2011 Feb 25.
Shields RK, Nguyen MH, Du C et al. Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum. Antimicrob Agents Chemother. 2011;55(6):2641-7. Epub 2011 Mar 21.
Shields RK, Nguyen MH, Press EG, Clancy CJ. Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicans. Antimicrob Agents Chemother. 2011;55(7):3598-602. Epub 2011 May 2.
Smithburger PL, Buckley MS, Bejian S et al. A critical evaluation of clinical decision support for the detection of drug-drug interactions. Expert Opin Drug Saf. 2011;10(6):871-82. Epub 2011 May 4.
Tan H, Tomic K, Hurley D, Daniel G, Barron R, Malin J. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study. Current Medical Research & Opinion 2011;27:79-86.
Tran T, Elliott RA, Taylor SE, Woodward MC. A Self-Administration of Medications Program to Identify and Address Potential Barriers to Adherence in Elderly Patients (January). Ann Pharmacother. 2011 Jan 12. [Epub ahead of print]
Tsuji BT, Okusanya OO, Bulitta JB, Forrest A, Bhavnani SM, Fernandez PB, Ambrose PG. Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead. Clin Infect Dis. 2011 Jun;52 Suppl 7:S513-9.
Weycker D, Malin J, Barron R, Edelsberg J, Kartashov A, Oster G. Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. American Journal of Clinical Oncology. Published online March 2, 2011.
Wombwell E, Murray C, Davis SJ et al. Leadership journal club. Am J Health Syst Pharm. 2011;68(21):2026-7.
Yee LL, Wright EA. Pitavastatin calcium: clinical review of a new antihyperlipidemic medication. Clin Ther. 2011 Aug;33(8):1023-42. Epub 2011 Aug 4.
Yost SE, Byrne R, Kaplan B. Transplantation: mTOR inhibition in kidney transplant recipients. Nat Rev Nephrol. 2011;7(10):553-5.
Yost SE, Srinivas T, Kaplan B. Ethical considerations regarding disparities pertaining to kidney transplant patients. Clin Pharmacol Ther. 2011;90(2):212-4.
Yost SE, Ranga KV, Kaplan B. Belatacept in renal transplantation. Dialysis and Transplant. 2011; 40: 33-36.
Yu JM, Shord SS, Cuellar S. Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia. J Oncol Pharm Pract. 2011;17(4):360-5.
Aspinall SL, Zhao X, Handler SM, Stone RA, Kosmoski JC, Libby EA, Francis SD, Goodman DA, Roman RD, et al. The quality of warfarin prescribing and monitoring in Veterans Affairs nursing homes. J Am Geriatr Soc. 2010;58:1475-1480.
Ballard SL, Wellborn-Kim JJ, Clauson KA. Effects of commercial energy drink consumption on athletic performance and body composition. Phys Sportsmed. 2010;38(1):107-17.
Benedict N. Virtual patients and problem-based learning in advanced therapeutics. Am J Pharm Educ. 2010;74(8):143.
Beri R, Chunduri S, Sweiss K, Peace DJ, Mactal-Haaf C, Dobogai LC, Shord S, et al. Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen. Bone Marrow Transplant. 2010;45(2):249-53.
Chan EW, Taylor SE, Marriott J, Barger B. An intervention to encourage ambulance paramedics to bring patients' own medications to the ED: impact on medications brought in and prescribing errors. Emerg Med Australas. 2010;22(2):151-8.
Coons JC, Plauger KM, Seybert AL, Sokos GG. Worsening heart failure in the setting of dronedarone initiation. Ann Pharmacother. 2010;44(9):1496-500.
Corman SL, Mohammad RA. Eltrombopag: a novel oral thrombopoietin receptor agonist. Ann Pharmacother. 2010;44(6):1072-9.
Costanzo MR, Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, Meiser B, Webber S, Baran D, Carboni M, Dengler T, Feldman D, Frigerio M, Kfoury A, Kim D, Kobashigawa J, Shullo M, et al; International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914-56.
D'Antonio N. Including motivational interviewing skills in the PharmD curriculum. Am J Pharm Educ. 2010;74(8):152d.
Devabhakthuni S, Seybert AL. Oral antiplatelet therapy for the management of acute coronary syndromes: defining the role of prasugrel. Crit Care Nurse. 2010 Jun 30 [published ahead of print]
Diehl JL, Daw JR, Coley KC, Rayburg R. Medical utilization associated with palivizumab compliance in a commercial and managed Medicaid health plan. J Manag Care Pharm. 2010;16(1):23-31.
Eisenhower C, Wilson SA. Comment: diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly. Ann Pharmacother. 2010;44(12):2039; author reply 2039-40.
Felix-Getzik E, Kuvin J, Karas R. Non-optimal HDL-C Levels Are Highly Prevalent in Patients Presenting with ACS and Well-Controlled LDL-C Levels. J Clin Lipidology. 2010;4(4):265-271.
Firstenberg M, Abel E, Blais D, Andritsos M. Delayed malignant hyperthermia after routine coronary artery bypass. Ann Thorac Surg. 2010;89(3):947-8.
Firstenberg MS, Abel E, Blais D, Louis LB, Steinberg S, Sai-Sudhakar C, Martin S, Sun B. The use of extracorporeal membrane oxygenation in severe necrotizing soft tissue infections complicated by septic shock. Am Surg. 2010;76(11):1287-9.
Firstenberg MS, Blais D, Abel E, Newton HB, Crestanello J. Emergent pulmonary embolectomy and advanced glioblastoma multiforme. Case Report Med. 2010;2010:862028. Epub 2010 Dec 20.
Firstenberg MS, Blais D, Abel E et al. Fulminant Neisseria meningitidis: role for extracorporeal membrane oxygenation. Heart Surg Forum. 2010;13(6):E376-8.
Firstenberg MS, Hasan A, Abel E, et al. Aortic rupture in a heart transplant patient following recent blunt aortic trauma. J Card Surg. 2010;25(2):240-2.
Fisher CL, Wilson SA. Pharmacy students' exposure to a culture of safety and their communication of medication errors. Am J Pharm Educ. 2010;74(9):176a; author reply 176b.
Ford DG, Seybert AL, Smithburger PL, Kobulinsky LR, Samosky JT, Kane-Gill SL. Impact of simulation-based learning on medication error rates in critically ill patients. Intensive Care Med. 2010;36(9):1526-31.
German P, Warren D, West S, Hui J, Kearney BP. Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV. J Acquir Immune Defic Syndr. 2010 Jul 30. [Epub ahead of print]
Gokhman R, Smithburger PL, Kane-Gill SL, Seybert AL. Pharmacologic and pharmacokinetic rationale for combination therapy in pulmonary arterial hypertension. J Cardiovasc Pharmacol. 2010 Sep 25. [Epub ahead of print]
Huang Y, Jiang B, Nuntanakorn P, Kennelly EJ, Shord S, Lawal TO, Mahady GB. Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro. Curr Drug Saf. 2010;5(2):118-24.
Jain L, Abraham S, Shord SS. The interactions of anti-cancer drugs approved in the last decade in the United States with membrane transporters. Anticancer Agents Med Chem. 2010;10(8):601-16.
Joy MS, Boyette T, Hu Y, et al. Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis. Eur J Clin Pharmacol. 2010 Jun 22. [Epub ahead of print]
Joy MS, Frye RF, Stubbert K, et al. Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases. J Clin Pharmacol. 2010;50(6):714-20.
Joy MS, Gipson DS, Powell L, et al. Phase 1 trial of adalimumab in focal segmental glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. Am J Kidney Dis. 2010;55(1):50-60
Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis. 2010;16(6):971-3.
Lavsa SM, Fabian TJ, Saul MI, Corman SL, Coley KC. Influence of medications and diagnoses on fall risk in psychiatric inpatients. Am J Health-Syst Pharm. 2010;67(15):1274-80.
Luong ML, Sareyyupoglu B, Nguyen MH, Silveira FP, Shields RK et al. Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection? Transpl Infect Dis. 2010;12(6):561-4. Epub 2010 Oct 7.
Martello JL, Pummer TL, Krenzelok EP. Cost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity. Clin Toxicol (Phila). 2010;48(1):79-83.
Mathias AA, German P, Murray BP, Wei L, Jain A, West S, Warren D, Hui J, Kearney BP. Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther. 2010;87(3):322-9.
McGrath SH, Snyder ME, Dueñas GG, Pringle JL, Smith RB, McGivney MS. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc (2003). 2010;50(1):67-71.
Minces LR, Gallagher DS, Shields RK. Acute retinal necrosis in a monocular patient complicated by acyclovir-induced nephrotoxicity. J Clin Virol. 2010;49(1):1-3.
Minces LR, Shields RK, Sheridan K, et al. Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literature. Anaerobe. 2010;16(4):327-30.
Momper JD, Zhang S, Randhawa PS, Shapiro R, Schonder KS, Venkataramanan R. Determination of cidofovir in human plasma after low dose drug administration using high-performance liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2010;53(4):1015-21.
Papadopoulos J, Smithburger PL. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations. Crit Care Med. 2010 Jun;38(6 Suppl):S126-35.
Pittenger AL, Starner CI, Thompson K, Gleason PP. Pharmacy students' views of managed care pharmacy and PBMS: should there be more exposure to managed care in the pharmacy curriculum? J Manag Care Pharm. 2010;16(5):346-54.
Pogue JM, Potoski BA, Kaye KS. Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Antimicrob Agents Chemother. 2010;54(6):2750. [Letter]
Rager A, Frey N, Goldstein SC, Reshef R, Hexner EO, Loren A, Luger SM, Perl A, Tsai D, Davis J, Vozniak M, et al. Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD. Bone Marrow Transplant. 2010 May 24. [Epub ahead of print]
Ramanathan S, Abel S, Tweedy S, West S, Hui J, Kearney BP. Pharmacokinetic interaction of ritonavir-boosted elvitegravir and maraviroc. J Acquir Immune Defic Syndr. 2010;53(2):209-14.
Randhawa PS, Schonder K, Shapiro R, Farasati N, Huang Y. Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation. 2010;89(12):1462-5.
Reddy T, Chopra T, Marchaim D, Pogue JM, et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother. 2010;54(5):2235-8.
Rickman S, Taylor DM, Taylor SE. An intervention trial increases the evidence-based use of bupivacaine in hand injuries. Emerg Med J. 2010;27(1):17-21.
Rothschild JM, Churchill W, Erickson A, Munz K, Schuur JD, Salzberg CA, Lewinski D, Shane R, Aazami R, Patka J, Jaggers R, Steffenhagen A, Rough S, Bates DW. Medication errors recovered by emergency department pharmacists. Ann Emerg Med. 2010;55(6):513-21.
Russo-Alvarez G. Encouraging the development of emotional intelligence in pharmacy schools. Am J Pharm Educ. 2010;74(8):152e.
Sam WJ, Joy MS. Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis. Ther Drug Monit. 2010;32(5):594-605.
Schafer JA, Kjesbo NK, Gleason PP. Dronedarone: current evidence and future questions. Cardiovasc Ther. 2010;28(1):38-47.
Schafer JA, Kjesbo NK, Gleason PP. Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis. J Manag Care Pharm. 2010;16(6):402-16.
Schafer JA, Gunderson BW, Gleason PP. Price increases and new drugs drive increased expenditures for multiple sclerosis. J Manag Care Pharm. 2010;16(9):713-7.
Schonder KS, Corman SL, Hung WY. Early risk factors for persistent anemia after kidney transplantation. Pharmacotherapy. 2010;30(12):1214-20.
Schonder KS, Mazariegos GV, Weber RJ. Adverse effects of immunosuppression in pediatric solid organ transplantation. Paediatr Drugs. 2010;12(1):35-49.
Sheridan KR, Potoski BA, Shields RK, Nau GJ. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis. Pharmacotherapy. 2010;30(12):1247-51.
Shord SS, Chan LN, Camp JR, et al. Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam. Br J Clin Pharmacol. 2010;69(2):160-6.
Shullo MA, Schonder K, Teuteberg JJ. Elevated tacrolimus levels associated with intravenous azithromycin and ceftriaxone: a case report. Transplant Proc. 2010;42(5):1870-2.
Smithburger PL, Kane-Gill SL, Benedict NJ, Falcione BA, Seybert AL. Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings. Ann Pharmacother. 2010;44(11):1718-24.
Smithburger PL, Kane-Gill SL, Nestor BL, Seybert AL. Recent advances in the treatment of hypertensive emergencies. Crit Care Nurse. 2010;30(5):24-30.
Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US. Drug Saf. 2010;33(10):879-88.
Smithburger PL, Seybert AL, Armahizer MJ, Kane-Gill SL. QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions. Expert Opin Drug Saf. 2010;9(5):699-712.
Stanton ML, Joy MS, Frye RF. Validation and application of a liquid chromatography-tandem mass spectrometric method for quantification of the drug transport probe fexofenadine in human plasma using 96-well filter plates. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(3-4):497-501.
Summers KM, Martin KE, Watson K. Impact and clinical management of depression in patients with coronary artery disease. Pharmacotherapy. 2010;30(3):304-22.
Sun HY, Shields RK, Cacciarelli TV, Muder RR, Singh N.A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient. Transpl Infect Dis. 2010 Jul 6. [Epub ahead of print]
Teuteberg JJ, Shullo MA, Zomak R, et al. Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. Am J Transplant. 2010;10(2):382-8.
Thomas L, Culley EJ, Gladowski P, Goff V, Fong J, Marche SM. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization. J Manag Care Pharm. 2010;16(2):122-9.
Weycker D, Barron RL. Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia. Cancer. 2010;116(12):3073. [letter]
Wisniewski CS. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome. Ann Pharmacother. 2010;44(4):658-67.
Witsil JC, Aazami R, Murtaza UI, Hays DP, Fairbanks RJ. Strategies for implementing emergency department pharmacy services: results from the 2007 ASHP Patient Care Impact Program. Am J Health-Syst Pharm. 2010;67(5):375-9.
Yu JM, Shord SS, Cuellar S. Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia. J Oncol Pharm Pract. 2010 Sep 8. [Epub ahead of print]
Zolopa AR, Berger DS, Lampiris H, Zhong L, Chuck SL, Enejosa JV, Kearney BP, Cheng AK. Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial. J Infect Dis. 2010;201(6):814-22.
American College of Clinical Pharmacy, Blair MM, Freitag RT, Keller DL, Kiser TH, Marrs JC, McGivney MS, Mohammad RA, Twedt EL; ACCP Certification Affairs Committee. Proposed revision to the existing specialty and specialist certification framework for pharmacy practitioners. Pharmacotherapy. 2009;29(4):3e-13e.
Bellamy CJ, Kane-Gill SL, Falcione BA, Seybert AL. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol. J Trauma. 2009;66(3):954-8.
Campara M, Shord SS, Haaf CM. Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach. J Clin Pharm Ther. 2009;34(2):207-13.
Ceresia ML, Fasser CE, Rush JE et al. The role and education of the veterinary pharmacist. Am J Pharm Educ. 2009;73(1):16.
Chan EW, Taylor SE, Marriott JL, Barger B. Bringing patients' own medications into an emergency department by ambulance: effect on prescribing accuracy when these patients are admitted to hospital. Med J Aust. 2009;191(7):374-7.
Coons JC, Barnes M, Kusick K. Takotsubo cardiomyopathy. Am J Health Syst Pharm. 2009;66(6):562-6.
Desai D, Goldbach-Mansky R, Milner JD et al. Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs. Ann Pharmacother. 2009;43:967-972.
Donihi AC, Weber RJ, Sirio CA, Mark SM, Meyer SM. An advanced pharmacy practice experience in inpatient medication education. Am J Pharm Educ. 2009;73(1):11.
Drusano GL, Okusanya OO, Okusanya AO et al. Impact of spore biology on the rate of kill and suppression of resistance in Bacillus anthracis. Antimicrob Agents Chemother. 2009 Aug 17. [Epub ahead of print]
Egorin MJ, Shah DD, Christner SM, Yerk MA, Komazec KA, Appleman LR, Redner RL, Miller BM, Beumer JH. Effect of a proton pump inhibitor on the pharmacokinetics of imatinib. Br J Clin Pharmacol. 2009;68(3):370-4.
Felix-Getzik E, Sylvia LM. Vancomycin-induced leukocytoclastic vasculitis. Pharmacotherapy. 2009;29(7):846-51.
Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009;79(2):135-40.
Forsberg EA. Response to Trujillo's article on "A Drug Interactions Elective Course". Am J Pharm Educ. 2009;73(7):126. [Letter]
Freeman MK, Lauderdale SA,Kendrach MG, Woolley TW. Google scholar versus PubMed in locating primary literature to answer drug-related questions . Ann Pharmacother. 2009;43(3):478-484.
Garcia GM, Snyder ME, McGrath SH, Smith RB, McGivney MS. Generating demand for pharmacist-provided medication therapy management: identifying patient-preferred marketing strategies. J Am Pharm Assoc (2003). 2009;49(5):611-6.
Gleason PP, Starner CI, Gunderson BW et al. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications. J Manag Care Pharm. 2009;15(8):648-58.
Gortney JS, Fagan A, Kissack JC. Neuroleptic malignant syndrome secondary to quetiapine. Ann Pharmacother. 2009;43(4):785-91.
Hall DL, Corman SL, Drab SR, Meyer SM, Smith RB. Instructor satisfaction with a technology-based resource for diabetes education. Am J Pharm Educ. 2009;73(3):45.
Hansen RA, Chin H, Blalock S, Joy MS. Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care. Res Social Adm Pharm. 2009;5(2):143-53.
Havrilla PL, Kane-Gill SL, Verrico MM, Seybert AL, Reis SE. Coronary vasospasm and atrial fibrillation associated with ondansetron therapy. Ann Pharmacother. 2009;43:532-536.
Hung WY, Kogelman L, Volpe G, Iafrati M, Davidson L. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents. 2009;34:486-9.
Joy MS, Dornbrook-Lavender K, Blaisdell J et al. CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases. Eur J Clin Pharmacol. 2009;65(9):947-53.
Joy MS, Gipson DS, Dike M et al. Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Clin J Am Soc Nephrol. 2009;4(1):39-47.
Joy MS, Hilliard T, Hu Y et al. Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Pharmacother. 2009;43(6):1020-7.
Joy MS, Hilliard T, Hu Y et al. Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy. 2009;29(1):7-16.
Kane-Gill SL, Bellamy CJ, Verrico MM, Handler SM, Weber RJ. Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU). Pharmacoepidemiol Drug Saf. 2009; 18:1185-1191.
Kearney BP, Mathias A. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives. Pharmacotherapy. 2009;29(8):924-9.
Kelley LR, Corman SL, Weber RJ. A pharmacy director’s primer on the American Recovery and Reinvestment Act of 2009. Hospital Pharmacy 2009;44:813-18.
Lauster CD, Gibson JM, DiNella JV, DiNardo M, Korytkowski MT, Donihi AC. Implementation of standardized instructions for insulin at hospital discharge. J Hosp Med. 2009;4(8):E41-2.
Lavsa SM, Corman SL, Verrico MM, Pummer TL. Effect of drug information request templates on pharmacy student compliance with the modified systematic approach to answering drug information questions. Ann Pharmacother. 2009;43(11):1795-801.
Lyman GH, Lalla A, Barron RL, Dubois RW. Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States. Clin Ther. 2009;31(5):1092-104.
Mathias AA, West S, Hui J, Kearney BP. Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure. Clin Pharmacol Ther. 2009;85(1):64-70.
McHayleh W, Sehgal R, Redner RL, Raptis A, Agha M, Natale J, et al. Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin. Leuk Lymphoma. 2009;50(11):1848-53.
Momary KM, Shapiro NL, Brace LD, Shord SS, Grossi E, Viana MA, Helgason CM, Nutescu EA, Cavallari LH. Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke. Cerebrovasc Dis. 2009;27(6):585-93.
Naeger Murphy N, Pile JC. Clinical Indications for Newer Antifungal Agents. Journal of Hospital Medicine 2009;4:102-11.
Nathan JP, Gim S. Responding to drug information requests. Am J Health Syst Pharm. 2009;66 706-711.
Noschese ML, DiNardo MM, Donihi AC et al. Patient outcomes after implementation of a protocol for inpatient insulin pump therapy. Endocr Pract. 2009;15(5):415-24.
Okusanya OO, Bhavnani SM, Hammel J et al. Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob Agents Chemother. 2009;53(9):3847-54.
Palkovic LB, Coley KC, Sokos DR. Factors associated with inappropriate inpatient prescribing of acid-suppressive therapy. International Journal of Pharmacy Practice 2009;17:73-75.
Patel GW, Patel N, Lat A et al. Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. Diagn Microbiol Infect Dis. 2009;64(2):236-40.
Pogue JM, DePestel DD, Kaul DR et al. Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract. Transpl Infect Dis. 2009;11(5):467-70.
Reider J, Donihi A, Korytkowski MT. Practical implications of the revised guidelines for inpatient glycemic control. Pol Arch Med Wewn. 2009;119(12):801-9.
Sahi J, Shord SS, Lindley C, Ferguson S, LeCluyse EL. Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes. J Biochem Mol Toxicol. 2009;23(1):43-58.
Schafer JA, Kjesbo NK, Gleason PP. Critical review of prasugrel for formulary decision makers. J Manag Care Pharm. 2009;15(4):335-43.
Shields RK, Martello JL, Potoski BA. Is vancomycin ototoxicity a significant risk? Antimicrob Agents Chemother. 2009;53(10):4572.
Shord SS, Shah K, Lukose A. Drug--botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals. Integr Cancer Ther. 2009;8(3):208-27.
Shord SS, Patel SR. Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines. J Exp Clin Cancer Res. 2009;28:76.
Shord SS, Bressler LR, Tierney LA, Cuellar S, George A. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm. 2009;66(11):999-1013.
Shord SS, Cavallari LH, Gao W, Jeong HY, Deyo K, Patel SR, Camp JR, Labott SM, Molokie RE. The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease. Eur J Clin Pharmacol. 2009;65(7):651-8.
Shrank WH, Gleason PP, Canning C, et al Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the target pharmacy label. J Gen Intern Med. 2009;24(5):570-8.
Shrank WH, Patrick A, Gleason PP et al. An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes. Med Care. 2009;47(9):1031-5.
Snyder ME, McGivney MS, Smith RB. Establishing a community practice research fellowship. Am J Pharm Educ. 2009;73(7):126.
Song X, Fowler R, Ruiz K, Hurley D, Barron RL. Impact of neutropenic complications on short-term disability in patients with cancer receiving chemotherapy. J Med Econ. 2009;12(2):154-63.
Starner CI, Norman SA, Reynolds RG, Gleason PP. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly. Am J Geriatr Pharmacother. 2009;7(1):11-9.
Suhrie EM, Hanlon JT, Jaffe EJ et al. Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother. 2009;7(1):20-5.
Watson K, Summers KM. Depression in patients with heart failure: clinical implications and management. Pharmacotherapy. 2009;29(1):49-63.
Wisniewski CS, Pummer TL, Krenzelok EP. Documenting drug information questions using software for poison information documentation. Am J Health Syst Pharm. 2009;66 1039-1043.
Wong AK, Stephens SB, Aspinall MB, Visweswaran S, Hanlon JT, Handler SM. Assessing the quality of prescribing and monitoring erythropoiesis-stimulating agents in the nursing home setting. J Am Med Dir Assoc. 2009;10(6):436-9.
Yeoh BS, Taylor DM, Taylor SE. Education initiative improves the evidence-based use of metoclopramide following morphine administration in the emergency department. Emerg Med Australas. 2009;21(3):178-83.
Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J, Drusano GL. Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. Diagn Microbiol Infect Dis. 2008;61(1):13-20.
Barkell M. Bleeding associated with warfarin use: improving outcomes. Arch Intern Med. 2008;168(2):236-7. Letter.
Bliden KP, DiChiara J, Lawal L, Singla A, Antonino MJ, Baker BA, Bailey WL, Tantry US, Gurbel PA. The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel. J Am Coll Cardiol 2008;52:531-3.
Coons JC, Battistone S. 2007 guideline update for unstable angina/ non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies. Ann Pharmacother 2008;42:989-1001.
Dauner DG, Deremer CE, Haburchak D. Clozapine-induced pericardial effusion. J Clin Psychopharmacol. 2008;28(4):455-6. Letter.
DeRemer CE. Vanlandingham J. Carswell J. Killough D. Pharmacy Outreach Education Program in Local Community. [letter]. American Journal of Pharmaceutical Education 2008;72(4) Article 94:1.
Donihi AC, Yang E, Mark SM, Sirio CA, Weber RJ. Scheduling of pharmacist-provided medication education for hospitalized patients. Hosp Pharm. 2008;43:121-126.
Drusano GL, Okusanya OO, Okusanya A et al. Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis? Antimicrob Agents Chemother. 2008;52(11):3973-9.
Elion R, Cohen C, Ward D, Ruane P, Ortiz R, Reddy YS, Ebrahimi R, McColl D, Kearney B, Fisher A, Flaherty J. BATON Study Group. Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naive patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily. HIV Clin Trials. 2008;9(4):213-24.
Ference JD, Medina MS. Modifying a traditional course for the PharmD curriculum. Am J Pharm Educ. 2008;72(5):122.
Gilreath JA, Sageser DS, Jorgenson JA, Rodgers GM. Establishing an anemia clinic for optimal erythropoietic-stimulating agent use in hematology-oncology patients. J Natl Compr Canc Netw. 2008;6(6):577-84.
Harris IM, Baker E, Berry TM, Halloran MA, Lindauer K, Ragucci KR, McGivney MS, Taylor AT, Haines ST. Developing a business-practice model for pharmacy services in ambulatory settings. Pharmacotherapy. 2008;28(2):285.
Israeli RS, Ryan CW, Jung LL. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. J Urol. 2008;179(2):414-23.
Johnson JL, McCarthy MW. Enteral administration of three proton-pump-inhibitor formulations. Am J Health-Syst Pharm. 2008;65(24):2324-5.
Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus. 2008;25(4):E3.
Joy MS, Dornbrook-Lavender KA, Chin H et al. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. Ann Pharmacother. 2008;42(1):9-15.
Lewis NJ, Bugdalski-Stutrud C, Abate MA, Blommel M, Wu CH, Gaither CA. The Medication Assessment Program: comprehensive medication assessments for persons taking multiple medications for chronic diseases. J Am Pharm Assoc. 2008;48(2):171-80.
Lionaki S, Hogan SL, Falk RJ, Joy MS, Jennette CE, Nachman PH, Jennette JC. Vasculitis and anti-thyroid medication. Nephrol Dial Transplant. 2008;23(5):1766-8. Letter.
Mathias AA, Hinkle J, Shen G, Enejosa J, Piliero PJ, Sekar V, Mack R, Tomaka F, Kearney BP. Effect of ritonavir-boosted tipranavir or darunavir on the steady-state pharmacokinetics of elvitegravir. J Acquir Immune Defic Syndr. 2008;49(2):156-62.
Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65(3):396-406.
Nkansah NT, Brewer JM, Connors R, Shermock KM. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. Am J Health-Syst Pharm. 2008;65(2):145-9.
Noschese M, Donihi AC, Koerbel G et al. Effect of a diabetes order set on glycaemic management and control in the hospital. Qual Saf Health Care. 2008;17(6):464-8.
Ramanathan S, Kakuda TN, Mack R, West S, Kearney BP. Pharmacokinetics of elvitegravir and etravirine following coadministration of ritonavir-boosted elvitegravir and etravirine. Antivir Ther. 2008;13(8):1011-7.
Rea RS, Capitano B, Bies R et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30(6):674-81.
Refaat M, McNamara D, Teuteberg J, Kormos R, McCurry K, Shullo M, Toyoda Y, Bermudez C. Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant. 2008;27(6):699-700. Letter.
Schwartz RN, Vozniak M. Current and emerging treatments for multiple myeloma. J Manag Care Pharm. 2008;14(7 Suppl):12-9.
Sevene E, Mariano A, Mehta U et al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf. 2008;31(10):867-76.
Shermock KM, Horn E, Rice TL. Erythropoietic agents for anemia of critical illness. Am J Health-Syst Pharm. 2008;65(6):540-6.
Shord SS, Bressler LR, Radhakrishnan L, Chen N, Villano JL. Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose. Ann Pharmacother. 2009;43(2):235-41.
Shord SS, Cavallari LH, Viana MA, Momary K, Neceskas J, Molokie RE, Deyo K, Patel SR. HYPERLINK "http://preview.ncbi.nlm.nih.gov/pubmed/18793590?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=10" Cytochrome P450 2C9 mediated metabolism in people with and without cancer. Int J Clin Pharmacol Ther. 2008;46(7):365-74.
Shord SS, Chew L, Villano J. Evaluation of opioid induced nausea and vomiting in sickle cell disease. Am J Hematol. 2008;83(3):196-9.
Shord SS, Cuellar S. Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation. J Am Pharm Assoc (2003). 2008;48(4):487-93.
Shord SS, Hamilton JM Jr, Cuellar S. Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia. J Oncol Pharm Pract. 2008;14(1):5-22.
Snyder CM, Helms BE, Hall DL. Evaluation of INR Monitoring Frequency and Time in Therapeutic Range. J Pharm Technol. 2008;24:255-60.
Starner C, Schafer S, Heaton AH, Gleason PP. Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated with Five Risk-Warning Events. Journal of Managed Care Pharmacy2008;14(6):523-31.
Starner C, Gleason PP. Cholinesterase Inhibitor Utilization Patterns: Just Because It Can Be Counted Does Not Mean It Counts. Journal of Managed Care Pharmacy 2008;14(5):462-464.
Sweiss KI, Beri R, Shord SS. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature. Drug Saf. 2008;31(11):989-96.
Tobia CC, Aspinall SL, Good CB, Fine MJ, Hanlon JT. Appropriateness of antibiotic prescribing in veterans with community-acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: a cross-sectional study. Clin Therap. 2008;30(6):1135-44.
Tomlinson D, Isitt JJ, Barron RL et al. Determining the understandability and acceptability of an oral mucositis daily questionnaire. J Pediatr Oncol Nurs. 2008;25(2):107-11
Van Rompay KK, Durand-Gasselin L, Brignolo LL, Ray AS, Abel K, Cihlar T, Spinner A, Jerome C, Moore J, Kearney BP, Marthas ML, Reiser H, Bischofberger N. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. Antimicrob Agents Chemother. 2008;52(9):3144-60.
Vila T, Gommer J, Scates AC. Role of gabapentin in the treatment of uremic pruritus. Ann Pharmacother. 2008;42(7):1080-4.
Vourvahis M, Tappouni HL, Patterson KB, Chen YC, Rezk NL, Fiscus SA, Kearney BP, Rooney JF, Hui J, Cohen MS, Kashuba AD. The pharmacokinetics and viral activity of tenofovir in the male genital tract. J Acquir Immune Defic Syndr. 2008;47(3):329-33.
Walbrown MA, Aspinall SL, Bayliss NK, Stone RA, Cunningham F, Squier CL, Good CB. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones. J Manag Care Pharm. 2008;14(1):34-40.
Abate MA, Blommel ML. A self-assessment tool for drug information advanced pharmacy practice experience. Am J Pharm Education 2007; 71(1): Article 02.
Benedict N, Seybert A, Mathier M, MD. Evidence-Based Pharmacologic Management of Pulmonary Arterial Hypertension. Clinical Therapeutics. 2007;29(10):2134-2153.
Benedict NJ. Sitaxsentan in the management of pulmonary arterial hypertension. Am J Health Syst Pharm 2007;64:363-368.
Coons JC, Fera T. Multidisciplinary team for enhancing care for patients with acute myocardial infarction or heart failure. Am J Health Syst Pharm 2007;64:1274-1278.
Coons JC, Seidl E. Cardiovascular pharmacotherapy update for the intensive care unit. Crit Care Nurs Q. 2007 Jan-Mar;30(1):44-57.
Corman SL, Skledar SJ, Culley CM. Evaluation of conflicting literature and application to formulary decisions. Am J Health-Syst Pharm 2007;64:182-185.
Corman SL, Skledar SJ. Use of lipid emulsion to reverse local anesthetic-induced toxicity. Ann Pharmacother. 2007;41(11):1873-7.
Deremer CE, Ford H, Lee Y. Lifestyle characteristics of medical center employees. Am J Health-Syst Pharm. 2007;64(19):2000-1. Letter.
Gleason PP, Shaughnessy AF. Telithromycin (Ketek) for Community Acquired Pneumonia. American Family Physician 2007;76:1857-8.
Gleason PP, Walters C, Heaton AH, Schafer JA. Telithromycin: the perils of hasty adoption and persistence of off-label prescribing. J Manag Care Pharm. 2007 Jun;13(5):420-5.
Gleason PP. Assessing step-therapy programs: a step in the right direction. J Manag Care Pharm. 2007 Apr;13(3):273-5.
Gortney JS, Sanders RM. Impact of C-reactive protein on treatment of patients with cardiovascular disease. Am J Health-Syst Pharm. 2007;64(19):2009-16.
Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease. Pharmacotherapy. 2007 May;27(5):734-44.
Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V. Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity. Nephrol Dial Transplant. 2007 Jul;22(7):1963-8. Epub 2007 Mar 29.
Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm. 2007 Jun;13(5):397-411.
Juang P, Fish DN, Jung R, Maclaren R. Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation. Pharmacotherapy. 2007;27(1):11-9.
Juang P, Skledar SJ, Zgheib NK, Paterson DL, Vergis EN, Shannon WD, Ansani NT, Branch RA. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. Am J Infect Control. 2007;35(2):131-7.
Juang P. Update on new antifungal therapy. AACN Adv Crit Care. 2007;18(3):253-60.
Kane-Gill SL, Olsen KM, Rebuck JA, Rea RS, Boatwright DW, Smythe MA et al. Aspiration Evaluation Group of the Clinical Pharmacy and Pharmacology Section. Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients. Ann Pharmacother. 2007;41(4):549-55.
Kockler DR, McCarthy MW. Zoster vaccine live. Pharmacotherapy. 2007 Jul;27(7):1013-9.
Kunze AM, Gunderson BW, Gleason PP, Heaton AH, Johnson SV. Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007. J Manag Care Pharm. 2007;13(9):799-806.
Lauderdale SA, Kendrach MG, Freeman MK. Preparing students for community pharmacy practice during a drug information advanced practice experience. Am J Pharm Educ. 2007;71(2):25.
Lauderdale SA, Kendrach MG, Freeman MK. Preparing students for community pharmacy practice during a drug information advanced practice experience. Am J Pharm Educ. 2007 Apr 15;71(2):25.
Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH. Association of thyroid disease and its treatment with ANCA small-vessel vasculitis: a case control study. Nephrol Dial Transplant. 2007 Aug 8; [Epub ahead of print]
Mathias AA, Hinkle J, Menning M, Hui J, Kaul S, Kearney BP. Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen Development Team. Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. J Acquir Immune Defic Syndr. 2007;46(2):167-73.
McGivney MS, Meyer SM, Duncan-Hewitt W et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc. 2007;47(5):620-8.
McMillen K, Weber RJ. Developing patient-centered pharmacy services through residency training. Hosp Pharm. 2007;42(8):756-759.
Mehta U, Durrheim D, Mabuza A et al. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa. Drug Saf. 2007;30(10):899-910.
Mehta U, Maartens G. Is it safe to switch between efavirenz and nevirapine in the event of toxicity? Lancet Infect Dis. 2007;7(11):733-8.
Noronha G, Miller J, Brewer JM. Pharmacists as nonphysician practitioners. Fam Pract Manag. 2007 Jan;14(1):11.
Okusanya O, Forrest A, DiFrancesco R, Bilic S, Rosenkranz S, Para MF, Adams E, Yarasheski KE, Reichman RC, Morse GD; ACTG 5043 Protocol Team. Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother. 2007 May;51(5):1822-6. Epub 2007 Feb 5.
Pogue JM, Paterson DL, Pasculle AW, Potoski BA. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 2007;28(12):1382-8.
Ramanathan S, Shen G, Cheng A, Kearney BP. Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. J Acquir Immune Defic Syndr. 2007;45(3):274-9.
Ramanathan S, Shen G, Hinkle J, Enejosa J, Kearney BP. Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavir. J Acquir Immune Defic Syndr. 2007;46(2):160-6.
Rea RS, Battistone S, Fong JJ, Devlin JW. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy. 2007 Apr;27(4):588-94.
Rea RS, Capitano B. Optimizing use of aminoglycosides in the critically ill. Semin Respir Crit Care Med. 2007;28(6):596-603.
Rea RS, Donihi AC, Bobeck M, Herout P, McKaveney TP, Kane-Gill SL, Korytkowski MT. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health Syst Pharm. 2007 Feb 15;64(4):385-95.
Shabsigh R, Duval S, Shah M, Regan TS, Juhasz M, Veltry LG. Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. Curr Med Res Opin. 2007;23(10):2453-60.
Skledar SJ, McKaveney TP, Sokos DR, Ervin KA, Coldren M, Hynicka L, Lavsa S, Reynolds R, Beauchamp R. Role of student pharmacist interns in hospital-based standing orders pneumococcal vaccination program. J Am Pharm Assoc. 2007;47(3):404-9.
Somma MA, Meyer SM. “Community of Learning” in experiential education. Am J Pharm Educ 2007;71(1): Article 19.
Szczesiul JM, Shermock KM, Murtaza UI, Siberry GK. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections. Pediatr Infect Dis J. 2007;26(9):852-4.
Taylor SE, Braitberg G, Lugt J. Multifaceted education initiative minimizes pethidine prescribing in the emergency department. Emerg Med Australas. 2007 Feb;19(1):25-30.
Watson K, Seybert AL, Saul MI, Lee JS, Kane-Gill SL. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention. Pharmacotherapy. 2007;27(5):647-656.
Zhang D, Carlson AM, Gleason PP et al. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers. J Manag Care Pharm. 2007;13(8):664-76.
Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin Ther. 2007;29(1): p 74-83. 2007.
